share_log

Tracon Pharmaceuticals | EFFECT: Others

Tracon Pharmaceuticals | EFFECT: Others

Tracon Pharmaceuticals | EFFECT：其他
美股SEC公告 ·  11/04 19:04

牛牛AI助理已提取核心訊息

Tracon Pharmaceuticals, Inc. has received a Notice of Effectiveness from the United States Securities and Exchange Commission (SEC) on November 1, 2024. The notice indicates that the company's submission, identified by Accession Number 0000950170-24-119598 and submission type POS AM, has been officially accepted by the SEC. The filing, under File Number 333-234651, marks a significant regulatory milestone for Tracon Pharmaceuticals.
Tracon Pharmaceuticals, Inc. has received a Notice of Effectiveness from the United States Securities and Exchange Commission (SEC) on November 1, 2024. The notice indicates that the company's submission, identified by Accession Number 0000950170-24-119598 and submission type POS AM, has been officially accepted by the SEC. The filing, under File Number 333-234651, marks a significant regulatory milestone for Tracon Pharmaceuticals.
tracon pharmaceuticals公司已於2024年11月1日收到了美國證券交易委員會(SEC)的生效通知。該通知表明，該公司的提交，由訪問號碼0000950170-24-119598和提交類型POS Am標識，已被SEC正式接受。根據文件編號333-234651進行的申報爲tracon pharmaceuticals標誌着重要的監管里程碑。
tracon pharmaceuticals公司已於2024年11月1日收到了美國證券交易委員會(SEC)的生效通知。該通知表明，該公司的提交，由訪問號碼0000950170-24-119598和提交類型POS Am標識，已被SEC正式接受。根據文件編號333-234651進行的申報爲tracon pharmaceuticals標誌着重要的監管里程碑。
有用
沒用

該公告為獨立文件：

獨立文件1

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間